Technical Analysis for LIVN - LivaNova PLC

Grade Last Price % Change Price Change
grade B 85.19 -1.08% -0.93
LIVN closed down 1.08 percent on Friday, September 13, 2019, on 66 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical LIVN trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength -1.08%
Above Upper BB Strength -1.08%
Overbought Stochastic Strength -1.08%
Upper Bollinger Band Touch Strength -1.08%
Above Upper BB Strength -1.34%
Overbought Stochastic Strength -1.34%

Older signals for LIVN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
LIVN Chart by TradingView
Basic chart:
Profile
Sand Holdco PLC, through its subsidiaries, Sand Holdco PLC Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, provides healthcare equipment. The company was incorporated in 2015 and is based in London, United Kingdom. Sand Holdco PLC operates as a subsidiary of Sorin SpA.
Medicine Neuroscience Nervous System Ion Television Neuromodulation Neurotechnology Healthcare Equipment
Is LIVN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Sep 13 LivaNova to Present Updates on Autonomic Regulation Therapy at the 23rd Annual Scientific Meeting of the Heart Failure Society of America
Sep 9 LivaNova's (LIVN) Study to Evaluate VNS Therapy Gets CMS Nod
Sep 5 LivaNova Receives Approval from U.S. Centers for Medicare & Medicaid Services for RECOVER Clinical Study
Sep 3 Did LivaNova PLC (NASDAQ:LIVN) Insiders Sell Shares?
Aug 30 LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2019
Aug 4 LivaNova PLC (LIVN) CEO Damien McDonald on Q2 2019 Results - Earnings Call Transcript
Aug 1 LivaNova PLC (LIVN) Q2 2019 Earnings Call Transcript
Jul 31 LivaNova PLC 2019 Q2 - Results - Earnings Call Slides
Jul 31 LivaNova Q2 top-line down 4%; reiterates guidance
Jul 31 LivaNova (LIVN) Q2 Earnings and Revenues Surpass Estimates
See more LIVN news...
Indicators
Indicator Value
52 Week High 126.99
52 Week Low 64.8
Average Volume 364,835
200-Day Moving Average 82.706
50-Day Moving Average 77.1028
20-Day Moving Average 79.547
10-Day Moving Average 80.979
Average True Range 2.3172
ADX 21.17
+DI 36.5752
-DI 15.4025
Chandelier Exit (Long, 3 ATRs ) 80.4984
Chandelier Exit (Short, 3 ATRs ) 81.3644
Upper Bollinger Band 86.5407
Lower Bollinger Band 72.5533
Percent B (%b) 0.9
BandWidth 17.583818
MACD Line 1.953
MACD Signal Line 1.0883
MACD Histogram 0.8647
Fundamentals Value
Market Cap 4.16 Billion
Num Shares 48.9 Million
EPS 0.56
Price-to-Earnings (P/E) Ratio 152.13
Price-to-Sales 2.96
Price-to-Book 1.92
PEG Ratio 1.64
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 87.94
Resistance 3 (R3) 88.06 87.28 87.48
Resistance 2 (R2) 87.28 86.58 87.21 87.32
Resistance 1 (R1) 86.23 86.15 85.84 86.11 87.17
Pivot Point 85.45 85.45 85.25 85.38 85.45
Support 1 (S1) 84.40 84.75 84.01 84.28 83.21
Support 2 (S2) 83.62 84.32 83.55 83.06
Support 3 (S3) 82.57 83.62 82.90
Support 4 (S4) 82.45